Clinical Trial Update: TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluated the safety and potential activity of TN-TC11G (THC+CBD) in combination with temozolomide and radiotherapy for newly d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• TN-TC11G (THC + CBD)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Grupo Español de Investigación en Neurooncología | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED